What factors drove the changes in Amn Healthcare Services's revenue and profit?

What were the key takeaways from Amn Healthcare Services's earnings call?

What guidance did Amn Healthcare Services's management provide for the next earnings period?

What were the key takeaways from Amn Healthcare Services’s earnings call?

What is Amn Healthcare Services's gross profit margin?

What is Amn Healthcare Services's latest dividend and current dividend yield?

What is the market's earnings forecast for Amn Healthcare Services next quarter?

What is the revenue and EPS growth rate for Amn Healthcare Services year over year?

- **Q4 2025 Results**: Revenue $748 million (+2% YoY), adjusted EBITDA $54 million. Labor disruption revenue $124 million (+100% YoY).
- **Q1 2026 Guidance**: Revenue $1.225-1.24 billion, including $600M disruption. Gross margin 23.5-24%.
- **Long-Term Growth**: 4-6% organic revenue growth, 10-15% EBITDA growth. AI and international staffing drive margin expansion.
- **Key Risks**: Labor disruption margin drag (300 bps in Q1), visa policy uncertainty.
- **Strategic Wins**: Kaiser contract renewal, new VMS clients, AI-enabled recruitment.


**【CEO Summary Section】**
- **Revenue Performance**: Full year 2025 revenue was $2.73 billion, with Q4 revenue of $748 million (2% YoY growth). Labor disruption revenue in Q4 was $124 million (nearly double YoY). Excluding disruption, Q4 revenue was $624 million, slightly above midpoint of guidance.
- **Segment Growth**: Nurse and Allied Solutions revenue grew 8% YoY to $491 million. Physician and Leadership Solutions revenue was $170 million (down 2% YoY). Technology and Workforce Solutions revenue was $88 million (down 18% YoY).
- **2026 Outlook**: Q1 2026 revenue expected to be $1.225-1.24 billion, including $600 million from labor disruption. Excluding disruption, Nurse and Allied revenue expected to grow 2-4% YoY. Full year 2026 targets: 4-6% organic revenue growth, 10-15% adjusted EBITDA growth.
- **Strategic Initiatives**: AI investments in recruitment, credentialing, and workforce management. Language Services tiered pricing strategy to improve margins. Expansion of VMS capabilities with ShiftWise Flex.

**【CFO Financial Commentary】**
- **Q4 2025 Results**: GAAP net loss of $8 million, adjusted EBITDA of $54 million (down 27% YoY). Gross margin 26.1%, reduced by 130 bps from labor disruption. DSO improved to 47 days (56 days excluding disruption). Operating cash flow $76 million.
- **Q1 2026 Guidance**: Revenue $1.225-1.24 billion, gross margin 23.5-24% (300 bps drag from disruption). SG&A 14.5-15% of revenue, including $40 million for disruption support. Adjusted EBITDA margin 9.7-10.2%.
- **Long-Term Targets**: 4-6% organic revenue growth, 10-15% EBITDA growth. Net leverage ratio target below 3x.

**【Q&A Highlights】**
- **Labor Disruption Management**: Dedicated strike team and event management system minimize disruption to core business. Q1 2026 labor disruption revenue expected to be $600 million, with potential for extension if strikes continue.
- **AI and Language Services**: Clinical language services protected by federal regulations. AI-enabled solutions for non-clinical interactions to expand revenue mix. Gross margin improvements expected in 2H 2026.
- **International Staffing**: Visa bulletin progress (Philippines +2 months) supports mid-teens growth in 2026. Focus on high-margin international nurse staffing.
- **Cash Flow and Capital Allocation**: 2025 free cash flow conversion above 60%. 2026 CapEx $36-45 million, focused on AI and system enhancements. Debt reduction target: below 3x leverage.


AMN Healthcare Services, Inc. (AMN) Q4 2025 Earnings Call Transcript

- **Revenue Beat**: Q3 revenue of $634 million (+8% YoY) exceeded guidance, driven by Nurse and Allied Solutions (+$12 million). Adjusted EBITDA margin of 9.1% was 20bps above guidance.
- **Gross Margin Volatility**: Q3 gross margin 29.1% (24.1% in Nurse and Allied), with Labor Disruption revenue boosting margins. Q4 gross margin expected to decline 100bps YoY due to mix and seasonality.
- **Strategic Growth**: 20%+ growth in international Nurse placements and VMS recovery in 2026. Travel Nurse bill rates set to rise modestly in Q4 for the first time in 3 years.
- **Financial Strength**: $53 million cash, $850 million debt (3.3x net leverage). Q4 guidance includes $100 million Labor Disruption revenue, with 2026 focus on margin recovery through contingent workforce solutions.

**【CEO Summary Section】**
- **Revenue Performance**: Q3 revenue of $634 million exceeded guidance, driven by Nurse and Allied Solutions (+$12 million) and strong demand in Travel Nurse and winter orders. Adjusted EBITDA was $57.5 million, 9.1% of revenue, above the high end of guidance.
- **Gross Margin Dynamics**: Consolidated gross margin was 29.1%, with Nurse and Allied segment gross margin at 24.1% (down 90bps YoY). Labor Disruption revenue contributed 150bps to Q3 gross margin but is expected to drag Q4 margins by 100bps.
- **Strategic Initiatives**: Investment in AI and technology (e.g., PreCheck predictive analytics) to improve clinician engagement and fill rates. International Nurse placements are expected to grow 20%+ in 2026, supporting margin recovery.
- **Demand Trends**: Travel Nurse demand rebounded 50% from mid-May lows, with modest year-over-year growth in winter orders. Permanent hiring activity fell, driving interest in contingent workforce solutions.

**【CFO Financial Commentary】**
- **Financial Highlights**: GAAP net income of $29 million, adjusted EPS of $0.39 (vs. $0.61 YoY). Operating cash flow of $23 million, with $53 million in cash and $850 million in debt (net leverage 3.3x).
- **Q4 Guidance**: Revenue $715-$730 million, gross margin 25.5%-26.0%, SG&A 20.0%-20.5% of revenue. Excluding Labor Disruption, gross margin would be ~26.5%.
- **Cost Management**: Sequential SG&A decline of $11 million (to $139 million) due to lower bad debt and reserve adjustments. Capital expenditures remain disciplined, with $8 million in Q3.

**【Q&A Key Highlights】**
- **Gross Margin Outlook**: Q4 gross margin expected to decline 100bps YoY due to Labor Disruption mix and seasonality. 2026 margin recovery driven by international placements, VMS growth, and bill rate normalization.
- **Demand Drivers**: Travel Nurse volume growth (+50% from mid-May lows), Locum Tenens MSP wins (+15% YoY), and schools business momentum. Language Services and VMS face pricing pressure but are expected to stabilize.
- **Competitive Landscape**: Clients increasingly prioritize total talent solutions platforms. Bill rates for Nurse and Allied Solutions expected to rise modestly in Q4 for the first time in 3 years.
- **Risk Management**: Debt refinanced to extend maturity to 2029, reducing carrying costs. Days sales outstanding improved to 57 days, reflecting strong collections.


AMN Healthcare Services, Inc. (AMN) Q3 2025 Earnings Call Transcript

- **Q2 Strong Performance**: Revenue of $658M exceeded guidance, with EBITDA of $58M and gross margin of 29.8%. Despite YoY declines, July saw demand stabilization in Allied and locum tenens.
- **Challenges and Recovery**: Travel Nurse orders down 25% YoY, but July extension rates rebounded. International nurse staffing to resume growth in Q4 2025.
- **Strategic Growth**: Allied Schools Q4 growth expected, and AI-driven solutions like Passport boost efficiency (20% of placements automated).
- **Financial Discipline**: Debt reduced to $920M, with Q3 guidance reflecting cautious outlook and $5M labor disruption support in revenue.
- **Market Position**: Retained market share in key segments, with MSP pipeline growth and vendor-neutral program traction.


**【CEO Summary Section】**
- Q2 revenue of $658 million exceeded guidance, with adjusted EBITDA of $58 million. Gross margin was 29.8%, driven by cost control and improved business mix.
- Challenges included delayed client decision-making due to policy uncertainty, leading to 15% decline in Travel Nurse orders from March to June. However, July saw rebounding extension rates and stabilization in Allied and locum tenens demand.
- Allied Schools business expects double-digit volume growth in Q4, while international nurse staffing is projected to resume sequential growth in Q4 2025, with outsized opportunities in 2026.
- AMN retained market share in Travel Nurse and Allied, and was named the largest healthcare leadership search firm by Modern Healthcare.

**【CFO Financial Commentary】**
- Q2 GAAP net loss was $116 million due to goodwill impairments, with adjusted EPS of $0.30. Operating cash flow was $79 million, and debt was reduced to $920 million.
- Smart Square sale generated $75 million, reducing annualized revenue by $17 million and EBITDA by $6 million. Q3 guidance projects revenue of $610-625 million, with gross margin of 28.7-29.2%.
- SG&A expenses are expected to be 23% of revenue, with focus on cost management and operational efficiency.

**【Q&A Highlights】**
- **Demand Trends**: July saw stabilization in Nurse and Allied demand, with Allied orders up 3% from March. Q3 orders remain below prior year levels but stable since mid-June.
- **Gross Margin**: Stabilization in bill rates and cost control contributed to margin improvements. International business expected to drive double-digit growth in 2026.
- **Strategic Initiatives**: Expansion of AI capabilities, Passport app adoption (20% of placements), and MSP growth with same-client sales up 5% in Q2.
- **Risks**: Legislative uncertainty impacts academic medical centers (20% of revenue), but July trends suggest clients are returning to flexible staffing solutions.


AMN Healthcare Services, Inc. (AMN) Q2 2025 Earnings Call Transcript

- **Revenue Beat & Margin Improvement**: Q1 $690M revenue (+15% YoY in key segments), 28.7% gross margin (vs. 27.7% Q4).
- **Cash Flow Strength**: $93M operating cash flow, $60M debt reduction, net leverage 3.1x.
- **Tech-Driven Growth**: AMN Passport adoption in locum tenens, ShiftWise Flex rollouts boost fill rates.
- **Upside Risks**: Labor disruption pipeline expansion, 5 new MSP/VMS wins, language services resilience.
- **Challenges**: Travel nurse volume decline (36% YoY), Spanish language services political headwinds.


**【CEO Opening Remarks】**
- Q1 2025 revenue of $690M exceeded high-end guidance by $10M, driven by labor disruption, locum tenens, and Allied businesses.
- Adjusted EBITDA of $64M and $93M in operating cash flow, reducing debt by $60M.
- Gross margin improved to 28.7%, with Nurse & Allied Solutions margin at 22.7% (90bps better than consensus).
- Technology investments (e.g., AMN Passport, ShiftWise Flex) enhance recruiter productivity and client retention.
- Strong pipeline in labor disruption and enterprise sales, with five new MSP/VMS wins.

**【CFO Financial Details】**
- GAAP net loss of $1M vs. $17M YoY; adjusted EPS of $0.45 (down 53% YoY).
- Sequential revenue decline of 6% (to $690M) due to lower travel nurse and interim leadership volumes.
- Nurse & Allied gross margin down 240bps YoY (22.7%) due to housing/per diem costs.
- Q2 2025 guidance: $645-660M revenue, 28.5-29% gross margin, and 7.8-8.3% EBITDA margin.

**【Q&A Key Highlights】**
- **Language Services Competition**: Consolidation in industry pressures margins, but AMN maintains high-quality, cost-effective solutions (5% QoQ growth).
- **Travel Nurse Bill Rates**: Stabilized YoY, with premium spread at 11% (vs. pre-pandemic 15-17%).
- **Labor Disruption Upside**: Pipeline strengthens, but revenue remains lumpy ($16M expected in Q2).
- **International Nursing**: Visa delays slow growth, but demand remains strong for rural/underserved areas.
- **Client Win Strategy**: Balanced MSP/VMS approach, with small-to-medium wins driving net client growth.


AMN Healthcare Services (AMN)-8 May 25-2025 Q1 Earnings call transcript

- **Q4 2024 Strong Finish**: Revenue ($735M) and EBITDA ($75M) beat expectations, driven by Nurse and Allied labor disruption revenue and Physician segment growth.
- **2025 Outlook**: Low-single-digit volume declines in core segments, with Technology and Workforce Solutions facing VMS headwinds. International business expected to recover in H2 2026.
- **Gross Margin Stability**: Nurse and Allied segment margin stabilizing near 22.5-23.5%, offsetting international headwinds. Physician segment margin compression from locum tenens spread.
- **Cash Flow Management**: $73M Q4 operating cash flow supports debt reduction; targeting 60-65% free cash flow conversion.
- **Technology Differentiation**: ShiftWise Flex, Passport, and WorkWise platform driving client engagement and long-term growth potential.


**【CEO Summary Section】**
- **Q4 2024 Financial Highlights**: Revenue of $735 million exceeded the high end of guidance by $30 million, with adjusted EBITDA of $75 million also surpassing expectations. Nurse and Allied Solutions outperformed by 6%, driven by labor disruption revenue. Physician and Leadership Solutions saw 3% growth from the MSDR acquisition. Technology and Workforce Solutions revenue rose 4%, led by language services.
- **Market Trends**: Travel nurse orders stabilized above April 2024 levels but remain 20% below pre-pandemic. Allied orders grew 7% YoY, and locum tenens demand outperformed seasonal norms. Gross margins across staffing businesses showed stabilization amid unfilled orders and vendor-neutral program growth.
- **2025 Outlook**: Expect low-single-digit volume declines in Nurse and Allied due to international visa retrogression. Physician segment revenue may dip slightly, while Technology and Workforce Solutions face low-single-digit headwinds from VMS volume declines.

**【CFO Financial Commentary】**
- **Q4 2024 Financials**: GAAP net loss of $188 million (driven by $222M goodwill impairment) vs. $12.5M YoY. Adjusted EPS of $0.75 vs. $1.32 YoY. Operating cash flow of $73M supported $75M revolver repayment, reducing net leverage to 3.0x.
- **Segment Performance**: Nurse and Allied gross margin declined 170bps YoY to 23.8%, impacted by international nurse revenue. Physician segment gross margin fell 480bps YoY due to locum tenens bill/pay spread compression. Technology segment gross margin dropped 320bps YoY on VMS mix shifts.
- **Q1 2025 Guidance**: Revenue $660-680M (-17% to -20% YoY), gross margin 28.1-28.6%, adjusted EBITDA margin 7.7-8.2%. International business expected to contribute $100M+ headwind in 2025, with stabilization in H2 2026.

**【Q&A Key Themes】**
- **Gross Margin Dynamics**: Nurse and Allied segment margin expected to stabilize near 22.5-23.5% in Q1, supported by stable bill rates and automation. International business headwinds (~$4-5M/Q1) offset by locum tenens and language services growth.
- **Client Behavior**: Hospitals reducing reliance on contract labor (average hours at 12-year lows) but turning to travel nurses for cost-effective flexibility. AMN's technology (ShiftWise Flex, Passport) positions it to capture share in both MSP and direct channels.
- **Competitive Landscape**: Intense competition for new clients, but rational pricing from staffing firms amid unfilled orders. AMN's scale and technology differentiation (e.g., WorkWise platform) support long-term growth despite near-term headwinds.
- **Free Cash Flow**: Targeting 60-65% conversion of adjusted EBITDA to free cash flow, with 2025 CapEx $40-50M.


Actual											0.79	0.83	0.82	1	1.7	1.64	1.73	2.95	3.49	3.31	2.57	2.48	2.49	2.38	1.97	1.32	0.97	0.98	0.61	0.75	0.45	0.3	0.39	0.22
Forecast											0.7798	0.6373	0.6911	0.8826	1.3688	1.4566	1.3033	2.6564	3.2005	2.9667	2.3689	2.141	2.3586	2.1447	1.6346	1.2526	0.9571	0.7773	0.5739	0.4881	0.2058	0.1822	0.2	0.2677
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+1.31%	+30.24%	+18.65%	+13.30%	+24.20%	+12.59%	+32.74%	+11.05%	+9.05%	+11.57%	+8.49%	+15.83%	+5.57%	+10.97%	+20.52%	+5.38%	+1.35%	+26.08%	+6.29%	+53.66%	+118.66%	+64.65%	+95.00%	-17.82%

AMN

AMN fundamentals

AMN Q4 2025 Earnings

Earnings Call

You can ask Aime

AMN

AMN fundamentals

AMN Q4 2025 Earnings

Earnings Call

AMN Earnings Call Summary for Q4/20255:00 PM on Feb 19, 2026

AMN Earnings Call Summary for Q3/20255:00 PM on Nov 6, 2025

AMN Earnings Call Summary for Q2/20255:00 PM on Aug 7, 2025

AMN Earnings Call Summary for Q1/20255:00 PM on May 8, 2025

AMN Earnings Call Summary for Q4/20245:00 PM on Feb 20, 2025

You can ask Aime